PB2194: HIGHER JAK2 ALLELE BURDEN IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS IS ASSOCIATED WITH HIGHER PREVALENCE OF CHRONIC KIDNEY DISEASE AND UNFAVORABLE DYNAMICS OF KIDNEY FUNCTION OVER TIME

PB2194: HIGHER JAK2 ALLELE BURDEN IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS IS ASSOCIATED WITH HIGHER PREVALENCE OF CHRONIC KIDNEY DISEASE AND UNFAVORABLE DYNAMICS OF KIDNEY FUNCTION OVER TIME

Bibliographic Details
Main Authors:	Marko Lucijanic, Petra Veic, Ivona Aric, Katarina Tupek, Ena Soric, Anica Sabljic, Josipa Vlasac Glasnovic, Tajana Stoos-Veic, Ivan Krecak, Rajko Kušec
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000975528.44799.64

Similar Items

Higher occurrence of chronic kidney disease in JAK2 V617F mutated MPN patients with higher mutant allele burden
by: Petra Veić, et al.
Published: (2023-01-01)

Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
by: Marko Lucijanic, et al.
Published: (2021-11-01)

PB2220: ATRIAL FIBRILLATION IS FREQUENT IN PATIENTS WITH MYELOFIBROSIS AND MIGHT BE SUB-OPTIMALLY TREATED
by: Marko Lucijanic, et al.
Published: (2023-08-01)

2194
by: Michael Khanjyan, et al.
Published: (2017-09-01)

P1040: HIGHER ESTIMATED PLASMA VOLUME STATUS IS ASSOCIATED WITH INCREASED THROMBOTIC RISK AND IMPAIRED SURVIVAL IN PATIENTS WITH PRIMARY MYELOFIBROSIS
by: M. Lucijanic, et al.
Published: (2022-06-01)

Cerebrovascular pulsatility index is higher in chronic kidney disease
by: Ester S. Oh, et al.
Published: (2023-01-01)

P1691: COMPARISON OF IMPROVE, MODIFIED IMPROVE, IMPROVEDD AND PADUA RISK SCORES FOR VENOUS THROMBOEMBOLISM PREDICTION IN HOSPITALIZED COVID-19 PATIENTS
by: M. Lucijanic, et al.
Published: (2022-06-01)

Chronic Kidney Disease Linked to Higher Incidence of Gastric Diseases
by: Xiaoliang Wang, et al.
Published: (2023-08-01)

Establishing a higher priority for chronic kidney disease in Peru
by: Elizabeth R Francis, et al.
Published: (2016-01-01)

Impact Pressure Distribution on a Monopile Structure Excited by Irregular Breaking Wave
by: Veic Duje, et al.
Published: (2018-05-01)

P1051: CLINICAL CHARACTERISTICS OF PULMONARY EMBOLISM IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS
by: Ivan Krecak, et al.
Published: (2023-08-01)

Chronic kidney disease patients who smoke have higher serum phosphorus
by: Geuza Dutra dos Santos, et al.
Published: (2018-12-01)

Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms
by: Ivan Krečak, et al.
Published: (2023-04-01)

Classification of Low-Resolution Flying Objects in Videos Using the Machine Learning Approach
by: STANCIC, I., et al.
Published: (2022-05-01)

PB2194: ISCHEMIC STROKE IN PATIENTS WITH THROMBOCYTOPENIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
by: M. Pérez Raya, et al.
Published: (2022-06-01)

High physical activity alleviates the adverse effect of higher sedentary time on the incidence of chronic kidney disease
by: Wonsuk Oh, et al.
Published: (2023-02-01)

Higher dietary inflammatory index is associated with increased all-cause mortality in adults with chronic kidney disease
by: Li-Jun Yan, et al.
Published: (2022-07-01)

Higher Prevalence and Progression Rate of Chronic Kidney Disease in Elderly Patients with Type 2 Diabetes Mellitus
by: Kyung-Soo Kim, et al.
Published: (2018-05-01)

P1039: PALPABLE SPLEEN SIZE IS PROGNOSTIC IN PRIMARY BUT NOT SECONDARY MYELOFIBROSIS
by: M. Lucijanic, et al.
Published: (2022-06-01)

Application of Infrared Thermography in an Adequate Reusability Analysis of Photovoltaic Modules Affected by Hail
by: Hrvoje Glavaš, et al.
Published: (2022-01-01)

P1563: REMDESIVIR USE IN SEVERE AND CRITICAL COVID-19 PATIENTS MIGHT BE ASSOCIATED WITH LOWER INCIDENCE OF ARTERIAL THROMBOTIC EVENTS
by: Marko Lucijanic, et al.
Published: (2023-08-01)

PB2219: POLYPHARMACY AND DRUG-TO-DRUG INTERACTIONS MAY HAVE A NEGATIVE EFFECT ON SURVIVAL IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS
by: Ivan Krecak, et al.
Published: (2023-08-01)

PB2127: NO IMPACT OF STATIN USE ON RESPONSE AND SURVIVAL RATES IN NEWLY DIAGNOSED DLBCL PATIENTS TREATED WITH R-DA-EPOCH
by: A. Sabljic, et al.
Published: (2022-06-01)

Peripheral Neuropathy Associated with Higher Mortality in Population with Chronic Kidney Disease: National Health and Nutrition Examination Surveys
by: Wei-Lan Li, et al.
Published: (2023-12-01)

C-reactive protein concentrations are higher in dogs with stage IV chronic kidney disease treated with intermittent hemodialysis.
by: Maria Gabriela Picelli de Azevedo, et al.
Published: (2022-01-01)

ERBP guideline on management of patients with diabetes and chronic kidney disease stage 3B or higher. Metformin for all?
by: Alberto Martínez-Castelao, et al.
Published: (2017-11-01)

Acute Kidney Injury and Chronic Kidney Disease
by: N. Kevin Krane
Published: (2012-01-01)

Chronic kidney disease
by: de Lusignan, S
Published: (2006)

Duffy‐null erythrocyte phenotype and the risk of thrombotic events in essential thrombocythemia
by: Ivan Krecak, et al.
Published: (2023-11-01)

Independent Determinants of Appetite Impairment among Patients with Stage 3 or Higher Chronic Kidney Disease: A Prospective Study
by: Chih-Chien Sung, et al.
Published: (2021-08-01)

Decreased B lymphocytes subpopulations are associated with higher atherosclerotic risk in elderly patients with moderate-to-severe chronic kidney diseases
by: Jieshan Lin, et al.
Published: (2021-11-01)

Non-dipping pulse rate and chronic changes of the kidney in patients with chronic kidney disease
by: Rina Oba, et al.
Published: (2023-02-01)

Genetics of osteopontin in patients with chronic kidney disease: The German Chronic Kidney Disease study.
by: Yurong Cheng, et al.
Published: (2022-04-01)

Bone Disease in Chronic Kidney Disease and Kidney Transplant
by: Ezequiel Bellorin-Font, et al.
Published: (2022-12-01)

Skeletal Muscle and Kidney Crosstalk in Chronic Kidney Disease
by: Kayte A. Jenkin, et al.
Published: (2022-10-01)

The gut–kidney connection in advanced chronic kidney disease
by: Reiko Inagi
Published: (2015-12-01)

Glucose-lowering therapies in patients with diabetes mellitus and chronic kidney disease
by: Minara Shamkhalovna Shamkhalova, et al.
Published: (2013-09-01)

Systemic mastocytosis in Croatia
by: Ivan Krečak, et al.
Published: (2022-10-01)

Lipids in chronic kidney disease.
by: Lewis, D, et al.
Published: (2010)

Chronic Kidney Disease and Nutrition
by: Sofia Acevedo, et al.
Published: (2021-02-01)